Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products.The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Company offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins.